Inventor · disambiguated record
Dominik Escher
Also filed as: ESCHER DOMINIK
14 granted patents·8 pending applications·93 citations·filing 1999–2025
91Inventor score
Files withESBATECH - A NOVARTIS COMPANY LLC4ESBATECH AG3ESBATECH ALCON BIOMED RES UNIT3BOEHRINGER INGELHEIM INT2CDR LIFE AG2
Top patents by PatentIndex Score
22 records- 0195US8399625B1Acceptor framework for CDR graftingESCHER DOMINIK·Filed 2010·Granted Mar 19, 2013·35 cites·6 claims
- 0288US7258986B2Intrabodies with defined framework that is stable in a reducing environment and applications thereofESBATECH AG·Filed 2000·Granted Aug 21, 2007·24 cites·6 claims
- 0387US8399624B1Acceptor framework for CDR graftingESCHER DOMINIK·Filed 2010·Granted Mar 19, 2013·5 cites·6 claims
- 0485US7258985B2Intrabodies with defined framework that is stable in a reducing environment and applications thereofESBATECH AG·Filed 2000·Granted Aug 21, 2007·14 cites·10 claims
- 0578US8853362B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameTISSOT KATHRIN·Filed 2003·Granted Oct 7, 2014·12 cites·9 claims
- 0673US2020362059A1Acceptor Framework for CDR GraftingESBATECH A NOVARTIS CO LLC·Filed 2020·Application pending·0 cites
- 0771US2020165322A1Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0865US9994645B2Acceptor framework for CDR graftingESBATech—a Novartis Company LLC·Filed 2016·Granted Jun 12, 2018·0 cites·9 claims
- 0964US9051366B2Acceptor framework for CDR graftingESBATECH·Filed 2013·Granted Jun 9, 2015·0 cites·4 claims
- 1064US9005924B2Acceptor framework for CDR graftingESBATECH·Filed 2013·Granted Apr 14, 2015·0 cites·4 claims
- 1163US10570190B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2018·Granted Feb 25, 2020·0 cites·1 claims
- 1262US9518108B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Dec 13, 2016·0 cites·10 claims
- 1362US9409979B2Acceptor framework for CDR graftingESBATech—a Novartis Company LLC·Filed 2015·Granted Aug 9, 2016·0 cites·5 claims
- 1462US9403903B2Acceptor framework for CDR graftingESBATech—a Novartis Company LLC·Filed 2015·Granted Aug 2, 2016·0 cites·5 claims
- 1562US2016304627A1Acceptor framework for cdr graftingESBATECH - A NOVARTIS COMPANY LLC·Filed 2016·Application pending·0 cites
- 1660US2022259296A1Complement c3 antigen binding proteinsBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1759US2025382357A1Complement c3 antigen binding proteinsBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 1858US10125186B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Nov 13, 2018·0 cites·10 claims
- 1958US2008233110A1Intrabodies with defined framework that is stable in a reducing environment and applications thereofESBATECH AG·Filed 2007·Application pending·0 cites
- 2052US2020024358A1Trispecific antigen binding proteinsCDR LIFE AG·Filed 2019·Application pending·0 cites
- 2151US2020062858A1Trispecific antigen binding proteinsCDR LIFE AG·Filed 2019·Application pending·0 cites
- 2237US6821728B1Screening systemUNIV ZUERICH·Filed 1999·Granted Nov 23, 2004·3 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Dominik Escher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →